Stroke is the third-leading cause of death in the United States, Canada, Europe, and Japan. According to the American Heart Association and the American Stroke Association, 750,000 new strokes occur each year, resulting in 200,000 deaths (or 1 of every 16 deaths) per year in the United States alone. Endovascular therapy for patients with acute ischemic stroke is an area of intense investigation. The American Stroke Association has given a qualified endorsement of intra-arterial (IA) thrombolysis in selected patients. IA thrombolysis has been studied in 2 randomized trials and numerous case series. Although 2 devices have been granted FDA 3 approval with an indication for mechanical stroke thrombectomy, none of these devices has demonstrated efficacy in improving patient outcomes. This report defines what constitutes adequate training to perform neuroendovascular procedures in patients with acute ischemic stroke and identifies the performance standards that should be adopted to assess outcomes. These guidelines have been written and approved by multiple neuroscience societies that historically have been directly involved in the medical, surgical, and endovascular care of patients with acute stroke, including the Neurovascular Coalition and its participating societies: 8 neither of these devices has demonstrated efficacy in improving patient outcomes despite a high rate of recanalization awaiting randomized trials. In this report we define what constitutes adequate training to perform neuroendovascular procedures in patients with acute ischemic stroke and identify the performance standards that should be adopted to assess outcomes. Neuroendovascular procedures are technically challenging and not directly transferable from other vascular systems, involve an organ with unique physiology and anatomy, and require careful patient selection because of the risk of potentially fatal brain hemorrhage. Studies of emerging technologies over the past 20 years have made it abundantly clear that inadequate physician training and experience can adversely affect clinical outcomes. 9, 10 Overexuberance by both physicians and industry has led unqualified physicians to perform endovascular carotid revascularization procedures, yielding inferior results. 9,10 Thus, it is especially important that the involved physicians strictly adhere to appropriate standards when performing high-risk procedures such as those involved in treating endovascular stroke. Standardization of training requirements is critically important as the interest in and utilization of endovascular methods increases among various specialties. These guidelines are modeled after earlier standards documents, such as the training, competency, and credentialing standards for diagnostic cerebral angiography, carotid stenting, and treatment of acute stroke, written and endorsed by multispecialty groups [11] [12] [13] During the next 2-3 years, as the nation progresses to regional stroke care with comprehensive stroke centers, it is conceivable that selective hospitals may choose to credential individuals for IA stroke therapy who have not had a full year of neurointerventional fellowship training. While this is not endorsed as best clinical practice, if such local situations occur and if hospitals choose to credential individuals who have not had a full year of neurointerventional training, then it is recommended that at a minimum these individuals should receive adequate neuroscience cognitive training, including a minimum of 6 months documented neuroscience training in an ACGME-approved postgraduate training program; adequate technical and interpretive cerebral angiography training, including a minimum primary operator experience of 100 appropriately supervised cerebral angiograms, which is the minimum prerequisite for neurointerventional training; adequate cerebral microcatheter experience, including a minimum of 30 cases as primary operator in the intracranial internal carotid artery/vertebral basilar circulation, mentored by a credentialed fellowship-trained neurointerventionalist; and mentored experience in IA stroke therapy, including a minimum of 10 cases mentored by a credentialed fellowship-trained neurointerventionalist credentialed in IA stroke therapy, before being credentialed to perform IA therapy.
It is anticipated that by 2012, stroke centers that are providing IA stroke therapy will be staffed exclusively with fellowship-trained neurointerventionalist and/or practitioners who have met the foregoing prerequisite guidelines and have demonstrated credentialed experience in IA therapy with adequate outcomes. It also is anticipated that after 2012, additional manpower for providing IA stroke therapy in stroke centers will come exclusively from fellowship-trained neurointerventionalists.
Training in Endovascular Surgical Neuroradiology
In the United States, Canada, Europe, and Japan, educational programs are specifically designed to train neuroscience physicians to treat acute hemorrhagic and ischemic stroke. This training represents the ''gold standard'' for performance of endovascular cerebrovascular procedures including the endovascular treatment of acute stroke.
Since the year 2000, program requirements have been formally established and published in North America to ensure uniform training in endovascular surgical neuroradiology, a field specializing in the endovascular treatment of acute stroke. 17 ''Endovascular surgical neuroradiology'' is the title or moniker used to describe the training pathway recognized by the ACGME. 17, 18 Mechanical revascularization (ie, thrombectomy/ embolectomy) devices have not yet been proven to improve patient outcomes. In addition, it is not possible to define general training requirements when there currently is significant clinical experience with only one mechanical revascularization clot-retrieval device and the necessary interventional skills for newer generations of clot-retrieval devices are unknown. Although there is consensus that the required skills and associated risks are greater for these devices than for catheter-based pharmacologic lysis, it is not possible to make specific training recommendations at this time. Nonetheless, at a minimum, the physician must meet the training criteria described herein for pharmacologic lysis for emergency stroke therapy and have successfully completed a training course for use of any specific device. Furthermore, the rates of procedural complications, including intracerebral hemorrhage, should conform to evidence-based national guidelines.
Maintenance of Physician and Facility Qualifications
Physicians should have ongoing stroke-specific continuing medical education (CME) of at least 15 hours every 2 years. Physicians also should have procedural outcomes that conform to national standards and institutional requirements.
Neuroendovascular procedures for acute ischemic stroke should be performed only at Joint Commissionor state-certified primary or comprehensive stroke centers. 19 Outlying and community hospitals should develop access via telemedicine or other means to obtain endovascular acute stroke therapy through the development of stroke systems of care if comprehensive stroke center capabilities are not available. 20 Interventionalists must have 24/7 access to neurologists and neurosurgeons knowledgeable in patient selection and in the preneurologic and postneurologic critical care of endovascularly treated stroke patients. There must be 24/7 neurology and neurosurgical availability to treat possible complications of stroke therapy. There must be an active quality assurance program for stroke therapy to monitor outcomes both in the periprocedural period and at 90 days. All patients who have received emergency intervention for stroke must be reviewed by this quality assurance program. Outcomes should be tracked and recorded. All centers should participate in and enroll all stroke patients in available national stroke registries or multicenter stroke trials.
Conclusions
Medical specialties with ACGME-approved training in neuroscience and the care of stroke patients agree on the importance of safety and quality of care for stroke patients. Due to the grave consequences of inadequate or deficient training, stringent credentialing criteria with formal neuroscience training as specified herein and by peer-reviewed published standards should be mandated for all providers of emergency endovascular stroke therapy, 17, 21 analogous to vascular interventions for acute myocardial infarction or other conditions with high morbidity and mortality. [22] [23] [24] [25] [26] [27] [28] [29] [30] Credentialing committees at each health care facility are empowered to enforce training and practice standards and thus have an obligation to maintain recognized accreditation standards and to be aware of recommendations endorsed by the national organizations most directly involved in the diagnosis and management of acute stroke. Physician credentials, maintenance of certification, and quality improvement programs must be consistent with mandated and accepted standards defined by the ACGME, American Medical Association (AMA), ABMS, and state licensing boards.
